Management of Refractory Septic Shock with DKA
Immediate Vasopressor Management
- The Society of Critical Care Medicine recommends titrating norepinephrine upward from the current dose to achieve MAP ≥65 mmHg, as norepinephrine remains the first-choice vasopressor with strong recommendation 1, 2
- The American College of Critical Care Medicine suggests adding vasopressin 0.03 units/min if norepinephrine requirements reach moderate-to-high doses, as this is recommended to either raise MAP to target or reduce norepinephrine dosage 1, 2
Critical Reassessment of Fluid Status
- The European Society of Intensive Care Medicine recommends stopping additional fluid boluses immediately given the CVP of 13 mmHg, which indicates adequate or excessive intravascular filling 4
- A CVP of 13 mmHg suggests the patient is unlikely to be fluid-responsive and further fluids risk pulmonary edema and worsening gas exchange 4
Assessment for Cardiac Dysfunction
- The Society of Critical Care Medicine recommends considering adding dobutamine (up to 20 mcg/kg/min) if there is evidence of persistent hypoperfusion with myocardial dysfunction despite adequate vasopressor therapy 1, 2
Corticosteroid Consideration
- The Surviving Sepsis Campaign recommends adding hydrocortisone 200 mg/day if hemodynamic stability cannot be achieved with adequate fluid resuscitation and vasopressor therapy 1, 2
Monitoring Targets
- The American College of Critical Care Medicine recommends targeting MAP ≥65 mmHg as the initial hemodynamic goal 1, 2, 5
- The Society of Critical Care Medicine suggests monitoring additional perfusion markers: lactate clearance, urine output ≥0.5 mL/kg/h, mental status, and skin perfusion 5
DKA-Specific Considerations
- The American Diabetes Association recommends aggressive insulin therapy and correction of acidosis to improve vasopressor responsiveness 1
Critical Pitfalls to Avoid
- The Society of Critical Care Medicine recommends not delaying vasopressor escalation waiting for additional fluid boluses when CVP is already elevated at 13 mmHg 4
- The European Society of Intensive Care Medicine suggests not using dopamine as first-line therapy; it should only be considered in highly selected patients with bradycardia and low arrhythmia risk 1, 2, 5